Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05398016 · ClinicalTrials.gov registry record · NA

Strategies for Treating Anxiety Research Study

A NA study of Anxiety and Anxiety Disorders, sponsored by University of Nevada, Las Vegas.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT05398016 is a NA study of Anxiety and Anxiety Disorders that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 27 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05398016, a NA study of Anxiety and Anxiety Disorders, has completed, sponsored by University of Nevada, Las Vegas.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This single-arm pilot clinical trial will evaluate the feasibility, acceptability, and engagement of target mechanism, and preliminary impact of a low-intensity behavioral intervention for mild-to-moderate anxiety disorders. Treatment will delivered by trained lay counselors ("coaches;" n = 5-6) to 2-5 patient participants each depending on enrollment and scheduling (n = up to 25).

Interventions

  • BEHAVIORAL low-intensity intervention for anxiety

Study Locations (1)

Nevada

  • University of Nevada Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2024-01-08
Est. Completion 2024-12-06
Phase NA

Sponsor

University of Nevada, Las Vegas

52 total trials

What the Registry Record Tells You About NCT05398016

The ClinicalTrials.gov registry entry for NCT05398016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which low-intensity intervention for anxiety is the first listed.

NCT05398016 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT05398016 about?

NCT05398016 is a clinical study titled "Strategies for Treating Anxiety Research Study". This single-arm pilot clinical trial will evaluate the feasibility, acceptability, and engagement of target mechanism, and preliminary impact of a low-intensity behavioral intervention for mild-to-moderate anxiety disorders. Treatment will delivered by trained lay counselors ("coaches;" n = 5-6) to ...

What is the current status of trial NCT05398016?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2024-01-08. Estimated completion is 2024-12-06.

What conditions does trial NCT05398016 study?

This clinical trial studies the following conditions: Anxiety, Anxiety Disorders.

What interventions are being tested in trial NCT05398016?

The interventions under investigation include: low-intensity intervention for anxiety (BEHAVIORAL).

Who is sponsoring clinical trial NCT05398016?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05398016 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.